B2B rare with singleron
As a project partner, Singleron Biotechnologies supports research for faster diagnoses and individual treatment approaches for rare neuromuscular diseases.
November 11, 2024
PRESS RELEASE
We are pleased that one of our tenants, Singleron Biotechnologies, is an important project partner in the “B2B-RARE” research project. The aim of the project is to accelerate the diagnosis and personalized treatment of rare neuromuscular diseases through innovative technologies.
You can find out more about this in the press release.
B2B rare with singleron
As a project partner, Singleron Biotechnologies supports research for faster diagnoses and individual treatment approaches for rare neuromuscular diseases.
November 11, 2024
PRESS RELEASE
We are pleased that one of our tenants, Singleron Biotechnologies, is an important project partner in the “B2B-RARE” research project. The aim of the project is to accelerate the diagnosis and personalized treatment of rare neuromuscular diseases through innovative technologies.
You can find out more about this in the press release.
B2B rare with singleron
As a project partner, Singleron Biotechnologies supports research for faster diagnoses and individual treatment approaches for rare neuromuscular diseases.
November 11, 2024
PRESS RELEASE
We are pleased that one of our tenants, Singleron Biotechnologies, is an important project partner in the “B2B-RARE” research project. The aim of the project is to accelerate the diagnosis and personalized treatment of rare neuromuscular diseases through innovative technologies.
You can find out more about this in the press release.